{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:35:03Z","timestamp":1761172503135,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.mycmed.2011.06.002","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T21:38:54Z","timestamp":1311457134000},"page":"214-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hallucinations auditives induites par le voriconazole\u00a0: illustration par le monitorage plasmatique"],"prefix":"10.1016","volume":"21","author":[{"given":"E.","family":"Ga\u00efes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Jebabli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Salouage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Charfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lakhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Klouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2011.06.002_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s15010-004-3121-1","article-title":"Voriconazole-induced musical hallucinations","volume":"32","author":"Agrawal","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0010","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mycmed.2007.05.004","article-title":"Metabolic drug-drug interactions of the azole antifungal drugs","volume":"17","author":"Billaud","year":"2007","journal-title":"J Myc Med"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijantimicag.2006.04.006","article-title":"Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman","volume":"28","author":"Elter","year":"2006","journal-title":"Int J Antimicrob agents"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0030","unstructured":"Henry M, Bolo N, Villafuerte R. MRI voriconazole brain concentrations. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, USA, 2009: Abstract A1-421."},{"key":"10.1016\/j.mycmed.2011.06.002_bib0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericine B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4414\/smw.2006.11547","article-title":"Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring","volume":"136","author":"Imbof","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/367933","article-title":"Voriconazole a new triazole antifungal agent","volume":"36","author":"Johnson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0050","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in nonneutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0055","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4140\/TCP.n.2008.804","article-title":"Adverse drug events complicate antifugal therapy for pulmonary aspergilloma","volume":"23","author":"Pakys","year":"2008","journal-title":"Consult Pharm"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740330903485637","article-title":"Voriconazole therapeutic drug monitoring: focus on safety","volume":"9","author":"Pasqualotto","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0070","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mycmed.2011.06.002_bib0080","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/588844","article-title":"Hallucinations during voriconazole therapy","volume":"47","author":"Zonios","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S115652331100076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S115652331100076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:15:11Z","timestamp":1761110111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S115652331100076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S115652331100076X"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2011.06.002","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hallucinations auditives induites par le voriconazole\u00a0: illustration par le monitorage plasmatique","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2011.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}